Overview of This Study:
The study involved four major activities to estimate the current size of the Laboratory Centrifuges Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.
Several stakeholders such as laboratory centrifuges products manufacturers, vendors, distributors, and technologists from hospitals and clinics were consulted for this report. The demand side of this market is characterized by the increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
Download PDF Brochure@
Projected Growth in Revenue:
The laboratory centrifuges market is projected to reach USD 2.2 billion by 2026 from USD 1.8 billion in 2021, at a CAGR of 4.0% from 2021 to 2026.
Growth Boosting Factors:
Increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges.
“Hospitals are expected to hold the largest share of the laboratory centrifuges market, by end user in 2021.”
Based on end user, the laboratory centrifuges market is segmented into hospitals, biotechnology & pharmaceutical companies, and academic & research institutes. The hospitals segment accounted for the largest share in the laboratory centrifuges market in 2020. The increasing prevalence of diseases, coupled with the growing awareness regarding early diagnosis & treatment, increasing demand for blood, availability of novel and technologically advanced centrifuges for blood separation, and growing number of hospitals, especially in emerging countries, are some of the key factors driving the growth of the laboratory centrifuges market for hospitals.
“North America commanded the largest share of the laboratory centrifuges market in 2021.”
Based on region, the laboratory centrifuges market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). In 2020, North America commanded the largest share of the laboratory centrifuges market. The large share of North America can be attributed to the rising R&D investments by government bodies, increasing emphasis on better management and the treatment of infectious diseases, and rapid growth in the pharmaceutical industry.
# In 2021, Eppendorf AG launched the Multipurpose Centrifuge 5910 Ri, which offers advanced features to enhance and simplify the process of centrifugation.
# In 2021, Sartorius announced to expand its presence in Michigan. Sartorius will open a new 130,000-square-foot (12,000-square-meter) state-of-the-art plant in Ann Arbor in late 2023. The new facility would focus on consolidating the existing business operations in Washtenaw County to create a center of excellence in Ann Arbor for the Laboratory and Bioprocess Products and Services in North America.
# In 2020, Eppendorf AG launched a refrigerated 24-place centrifuge 5425 R, which offers protection to temperature-sensitive samples and offers immediate cooldown of temperature 8 minutes (21° C to 4°C); these centrifuges come with six rotors.
# In 2020, Eppendorf expanded its production of centrifuges in Leipzig, Germany.
# In 2019, Thermo Fisher Scientific acquired, within the Laboratory Products and Services segment, Brammer Bio for approximately USD 1.67 billion in cash. Brammer Bio is a leading viral vector contract development and manufacturing organization for gene and cell therapies. The acquisition expanded the segment’s contract manufacturing capabilities. Brammer Bio reported revenues of approximately USD 140 million in 2018.
# In 2018, Andreas Hettich GmbH & Co.KG launched its dual centrifuge ZentriMix 380 R, which facilitates numerous routine tasks of the research and analytical laboratories.
Request Sample Pages@